Brief: MEI Pharma Announces Changes To Board Of Directors
22/09/2022 13:09
Sept 22 (Reuters) - MEI Pharma Inc MEIP.O :
* MEI PHARMA ANNOUNCES CHANGES TO BOARD OF DIRECTORS
* MEI PHARMA INC - CHRISTINE A. WHITE HAS DECIDED TO RETIRE
AND
THUS DOES NOT INTEND TO STAND FOR REELECTION AT CO'S FY23 ANNUAL
STOCKHOLDERS MEETING
* MEI PHARMA INC - CHARLES V. BALTIC III HAS BEEN ELECTED TO
REPLACE DR. WHITE AS CHAIR OF BOARD
Source text for Eikon: ID:nBw92krRta
Further company coverage: MEIP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lite Strategy
See all newsBrief: Lite Strategy Receives Governance Rights And Option To Buy Litvm Future Network Tokens
U.S. RESEARCH ROUNDUP- Equinix, KLA, WW Grainger
Brief: Lite Strategy Inc - On Nov 14, Board Approves Justin J. File As Permanent CEO - SEC Filing
Brief: Lite Strategy Reports First Quarter Fiscal Year 2026 Results Highlights Successful Launch Of $100M Litecoin Treasury Strategy And Movement Into Active Capital Market Operations
Brief: Lite Strategy Announces $25M Share Repurchase Program, Signaling Shift From Initial Litecoin Accumulation To Active Capital Market Operations